期刊文献+

老年重症肺炎患者血清内脂素变化的临床意义 被引量:1

Clinical significance ofvisfatin in elderly patient with severe pneumonia
在线阅读 下载PDF
导出
摘要 目的探讨老年重症肺炎患者血清内脂素水平变化的临床意义。方法采用前瞻性研究,选择老年重症肺炎患者59例,老年非重症肺炎患者77例,及30例健康老年体检者作对照组。检测三组血清内脂素、TNF—α、CRP、白细胞介素6(IL-6)、白细胞介素8(IL-8)。老年重症肺炎和非重症肺炎组进行血气分析、APACHEⅡ评分。结果与对照组比较,老年重症肺炎组内脂素高于非重症肺炎组及对照组(P均〈0.01),非重症肺炎组内脂素亦高于对照组(P〈0.01)。老年重症肺炎组中内脂素水平与TNF—α、CRP、IL-6、IL-8呈正相关俨〈0.05),与PaO2、氧合指数呈负相关俨〈0.05)。结论老年重症肺炎患者血清内脂素升高,提示内脂素可能是一种促炎脂肪细胞因子,对于重症肺炎病情严重程度的判断具有一定的临床意义。 Objective To evaluate the value of the plasma visfatin levels in elderly patients with severe pneumonia. Methods The data of 59 elderly patients with severe pneumonia and 77 elderly patients with non-severe pneumonia as well as 30 elderly healthy individuals were analyzed, prospectively. The plasma levels ofvisfatin, TNF-α, CRP, IL-6, IL-8 were assayed. The blood gas analysis and Acute Physiology and Chronic Health Evaluation Ⅱ ( APACHE Ⅱ ) were carried out in patients with pneumonia. Results The plasma levels of visfatin in the severe pneumonia group were significantly higher than those in the non-severe pneumonia group and the control group (P〈0.01, respectively ). The plasma levels of visfatin in non-severe pneumonia group were also higher than those in control (P〈0.05). The plasma level of visfatin was positively correlated with TNF-α, CRP, IL-6 and IL-8 (/9〈0.05), while negatively correlated with PaO2 and oxy- genation index (P〈0.05). Conclusions Serum level of visfatin increases in elderly patients with severe pneumonia. Visfatin may be an important proinflammatory adipocytokine and is valuable in assessing the severity of pneumonia.
出处 《老年医学与保健》 CAS 2012年第4期227-228,235,共3页 Geriatrics & Health Care
关键词 重症肺炎 内脂素 肿瘤坏死因子-α C反应蛋白 白细胞介素6 白细胞介素8 急性生理与慢性健 康状况Ⅱ评分 老年 Severe pneumonia Visfatin Tumor necrosis factor-α C-reactiveprotein Interleukin-6 Interleukin-8 Acute physiology and chronic health evaluation Ⅱ score Elderly
  • 相关文献

参考文献9

  • 1Gomez R, Conde J, Scotece M, et al. What's new in our understanding of the role of adipokines in rheumatic diseases? [J]. Nat RevRheumatol, 2011, 7 (9): 528-536.
  • 2Kukla M, Mazur W, Bu dak RJ, etal. Potential role ofleptin, adiponectin and the novel adipokines-visfatin, chemerin and vas- pin-in chronic hepatitis [J]. Mol Med, 2011, 17 (11-12): 1397-410.
  • 3Kang YS, Song HK, Lee MH, et al. Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients [J]. Diabetes Res Clin Pract, 2010, 89 (2): 141-149.
  • 4Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity [J]. Endocr Regul, 2010, 44(1): 25-36.
  • 5Cekmez F, Canpolat FE, Cetinkaya M, et al. Diagnostic value of resistin and visfatin, in comparison with C-reactive pro- tein, procalcitonin and interleukin-6 in neonatal sepsis [J]. Eur CytokineNetw, 2011, 22 (2): 113-117.
  • 6社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3072
  • 7Saddi-Rosa P, Oliveira CS, Giuffrida FM, et al. Visfatin, glucose metabolism and vascular disease: a review of evidence [J]. DiabetolMetabSyndr, 2010, 2: 21.
  • 8HongSB, HuangY, Moreno-VinascoL, etal. Essentialrole of pre-B-cell colony enhancing factor in ventilator-induced lung injury [J]. Am J Respir Crit Care Med, 2008, 178 (6): 605-617.
  • 9Jia SH, Li Y, Parodo J, Kapus A, et al. Pre-B cell colony- enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis [J]. JClinlnvest, 2004, 113 (9): 1318-1327.

二级参考文献24

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:790
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.

共引文献3068

同被引文献18

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部